Effect of dhanyakadi ghana vati in the patients having symptoms of grahani roga.

A comparative clinical study to evaluate the efficacy of dhanyakadi ghan vati with ushana jala & takra in the management of grahani roga.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017701

Enrollment

Registered

2019-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E888- Other specified metabolic disorders

Interventions

Intervention1: GROUP-A: 20 patients will be treated with dhanyakadi ghan vati with anupan of takra 1TDS in which each tablet are 500mg given oraly for 45 days and the assessment of the patients will

Eligibility

Inclusion criteria

Inclusion criteria: patients should fullfill both the subjective and objective criteria.

Exclusion criteria

Exclusion criteria: patients suffering from chronic illness or any systemic failure, and who have not fullfilling the sunjective or objective parameters.

Design outcomes

Primary

Measure	Time frame
To assess the effect of drugs,subjectively all sign and symptoms were given scoring depending upon their severity. No sign-0 Mild-1 Moderate-2 severe-3 and objectively changes in stool like frequency,mucus,blood and ova cyst in stool.Timepoint: To assess the effect of drugs,subjectively all sign and symptoms were given scoring depending upon their severity. No sign-0 Mild-1 Moderate-2 severe-3 and objectively changes in stool like frequency,mucus,blood and ova cyst in stool.for 45 days of study.	—

Measure

Time frame

To assess the effect of drugs,subjectively all sign and symptoms were given scoring depending upon their severity. No sign-0 Mild-1 Moderate-2 severe-3 and objectively changes in stool like frequency,mucus,blood and ova cyst in stool.Timepoint: To assess the effect of drugs,subjectively all sign and symptoms were given scoring depending upon their severity. No sign-0 Mild-1 Moderate-2 severe-3 and objectively changes in stool like frequency,mucus,blood and ova cyst in stool.for 45 days of study.

—

Secondary

Measure	Time frame
Excerbation in sign and symptomsTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDr sanjay kumar tripathi

Rishikul campus uttarakhand ayurveda university haridwar uttarakhand

Sanjaytripathi.230@rediffmail.com9411503035

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026